Individuals with a BMI of 30 or above, or 27 or above with weight-related comorbidities, under qualified medical supervision
We restricted the analysis to phase 1, 2, and 3 studies
In a small-scale study of older patients with T2DM and mild cognitive impairment (n = 250), DPP4i-based glucose-lowering therapy was associated with a slower deterioration of cognitive function, mainly attentional and executive functions, compared to the sulfonylurea-based glucose-lowering therapy over a 2-year follow-up (Odds ratio: 0.88, 95% CI 0.450.99, p = 0.03) ( versus metformin group over 6 months in patients without AD: 0.95 2.17 versus 2.50 3.03) ( et al
Anti-aging peptides for fertility are small chains of amino acids that have been researched for their ability to promote reproductive well-being
At ThinWorks, every peptide therapy protocol begins with a thorough clinical evaluation and laboratory testing to confirm candidacy and establish a safe, personalized dosing plan